Life Sciences Client Partner, NorCal Growth Leader

Slalom Build; San Francisco (CA); On-site; USD 171,000 - 293,000; Full time

Benefits offered by this job

Paid holidays

401(k) with match

Health, dental, & vision coverage

Well-being reimbursement

Parental leave

Job summary

Slalom Build in San Francisco is seeking a Client Partner to enhance their Life Sciences portfolio. The ideal candidate will drive growth with biopharma, medtech, and emerging organizations, managing relationships and ensuring delivery excellence.

This role requires extensive consulting experience in Life Sciences and a strong network in the Northern California market. Compensation ranges from $171,000 to $293,000 based on experience, with an additional bonus possibility. A commitment to equitable compensation and transparency is upheld.

Qualifications

• Prior consulting experience with external clients focusing on Life Sciences.
• Strong network within Life Sciences clients in Northern California.
• Proven ability to build executive-level relationships.
• Demonstrated success in business development.
• Experience leading complex consulting engagements.

Responsibilities

• Own and grow a portfolio of Life Sciences clients.
• Act as a strategic advisor to client leaders.
• Drive business development activities.
• Develop and execute account strategies.
• Provide executive oversight and governance.

Skills

Consulting experience

Business development

Relationship building

Problem-solving skills

Negotiation skills

Job description

Slalom Build in San Francisco is seeking a Client Partner to enhance their Life Sciences portfolio. The ideal candidate will drive growth with biopharma, medtech, and emerging organizations, managing relationships and ensuring delivery excellence.

This role requires extensive consulting experience in Life Sciences and a strong network in the Northern California market. Compensation ranges from $171,000 to $293,000 based on experience, with an additional bonus possibility. A commitment to equitable compensation and transparency is upheld.